6 Oct 2022

Soft Mist Inhalers (SMIs) Based on Pre Filled Syringes

Resyca, a joint venture between Recipharm and Medspray, is developing a novel type of soft mist inhaler devices, based on an existing primary packaging: glass pre filled syringes. This way we can utilise existing filling lines within Recipharm to do the aseptical filling. The lecture will describe the devices and the typical timelines for clinical and commercial supply.

Most pharma and biological companies perform their drug discovery, pre clinical and phase 1 clinical work with nebulisers and liquid formulations. By using a soft mist inhaler device, they can take a shortcut and reach the market sooner and with lower development risks. Resyca's soft mist inhalers have been developed with biologics formulations in mind, being able to deliver milligrams of drug in a single inhalation from a pocket size device.

Click here to register

Content provided by our supplier

Recipharm AB

  • SE
  • 2015
    On CPHI since
  • 5000+
Company types
Contract Service

Other Content from Recipharm AB (14)